Press "Enter" to skip to content

Cancer Diagnostics Market 2019: Comprehensive Analysis by Top Key Companies, Industry Growth, Size, Share, Market Insights, Sales Volume and Forecast to 2024


The “Cancer Diagnostics Market” research report 2019-2024 delivers comprehensive information and valuable insights about the Cancer Diagnostics industry. The information available in the Cancer Diagnostics market report is not only based on the facts but also on the case studies, which analysts have included to convey appropriate information to the clients in a well-versed manner. Cancer Diagnostics market report includes valuable information to assist new entrants, as well as established players, to understand the prevailing trends in the market.

Some Companies Are Covered in the Cancer Diagnostics Market:

  • Abbott
  • Qiagen
  • F. Hoffmann
  • La Roche Ltd
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • GE Healthcare
  • Hologic Inc.
  • Illumina Inc
  • Philips Healthcare
  • Agilent Technologies Inc

    Get a Sample Copy of the Report –

    Market Overview:

  • Increase in the number of cancer cases and the rise in geriatric population are the major factors which are attributing for the growth of the Cancer Diagnostics market globally. As per the WHO statistics, cancer accounts for 13% of deaths globally every year, moreover, 70% increase in cancer incidences is anticipated over the next couple of decades and global geriatric population is anticipated to nearly double from 12% to 22% from 2015 to 2022. Furthermore, increase in the emergence of new technologies like biomarkers and point of care testing, inclination towards advanced less-painful and way more efficient tests from conventional tests, improved healthcare expenditure, growing awareness, and increased government support are the few more factors which are boosting the growth of the Cancer Diagnostics market globally. However, stringent regulatory framework, lack of universal health coverage, expensive diagnostic procedures, prolonged time of approvals for product launching and cost containment measures are the few factors restraining the growth of Cancer Diagnostics market globally.

    Scope of the Report:

  • Cancer is a complex disease that impacts every patient differently. Comprehensive and personalized treatment starts with an accurate, thorough diagnosis that includes radiology, pathology, genetics and advanced genomic testing. Sophisticated tests and procedures are used to measure the stage and progression of the disease and identify the tumor’s type, size, and location.
  • Cancer diagnosis begins with a thorough physical exam and a complete medical history. Laboratory studies are performed to detect abnormalities that may indicate cancer. When a tumor is suspected, imaging tests help doctors to determine cancer’s location and size. To confirm the diagnosis of most cancers, a biopsy needs to be performed in which a tissue sample is removed from the suspected tumor and studied under a microscope to check for cancer cells. If the diagnosis is positive (cancer is present), other tests are performed to provide specific information about cancer. If the initial diagnosis is positive for cancer and symptoms persist, further tests may be needed and the further treatment is started.

    Reasons for Buying Cancer Diagnostics Market Report:

    • This report provides pin-point analysis for changing competitive dynamics
    • It provides a forward looking perspective on different factors driving or restraining market growth
    • It provides a five-year forecast assessed on the basis of how the market is predicted to grow
    • It helps in understanding the key product segments and their future
    • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
    • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

    For More Information or Query or Customization Before Buying, Visit at –

    Key Market Trends:

    Imaging Test is expected to dominate the Cancer Diagnostics Market

    The most commonly used screening test for cancer is diagnostic imaging tests. The different kinds of imaging techniques for cancer detection are Imaging (Radiology) Tests for Cancer, CT Scans, MRI, Nuclear Medicine Scans, Ultrasound, Mammograms, X-rays and Other Radiographic Tests and are considered as the most reliable ones. Factors that are responsible for the growth of this segment include the increasing awareness about the early detection of cancer, the growing incidence of various types of cancer, and the increasing government initiatives and support. Mammograms are the most widely used tests to diagnose cancers. Mammography is the gold standard technique used to screen breast cancer, governments and other healthcare organizations around the world are taking initiatives to provide women, between the ages of 50 and 75, access to mammography screening. As per the, about one in eight US women (about 12.4%) will develop invasive breast cancer over the course of their lifetime. In 2018, an estimated 266,120 new cases of invasive breast cancer are anticipated to be diagnosed in women only in the United States, along with 63,960 new cases of non-invasive breast cancer.

    The Asia Pacific is anticipated to grow rapidly in the global Cancer Diagnostics market

    Asia-Pacific is expected to record a substantial growth over the forecast period, due to the existence of a large patient pool, availability of skilled professionals at a reasonable cost, and a distinct regulatory framework supporting accelerated product approvals and growing economic developments in countries like China and India and improved healthcare infrastructure. According to India Against Cancer report, total deaths due to cancer in 2018 in India are 7, 84,821 out of which 4,13,519 are Men and 3,71,302 are Women. Market players in the APAC region are involved in partnerships and agreements to enhance the market growth in Cancer Diagnostics. For instance, In April 2019, Halifax signs an exclusive agreement with Genecast to make Immunoscore® available in China. In June 2017, Agilent Technologies Inc. and Agendia, Inc. have entered into an agreement to expand their relationship to include the development of an RNA-Seq kit version of Agendia’s currently marketed MammaPrint and BluePrint tests.

    Cancer Diagnostics Market Report Provides Comprehensive Analysis of:

    • Functional market industry outline
    • Up and downstream industry examination
    • Channels and propositions believability
    • Market challenge by key players
    • Enhancement suggestions examination

    Purchase this Report (Price 4250 USD for single user license) –

    Report Highlights:

    • Market Dynamics – Drivers, Restraints, and Opportunities
    • Market Segmentation – Types, Applications, Regions, and Technology
    • Market Trends
    • Competitive Landscape
    • SWOT Analysis and Porter’s Five Forces Analysis

    Detailed TOC of Cancer Diagnostics Market Report 2019-2024:

    1.1 Study Deliverables
    1.2 Study Assumptions
    1.3 Scope of the Study



    4.1 Market Overview
    4.2 Market Drivers
    4.2.1 Increasing Ease of Cancer Diagnosis
    4.2.2 ncreasing Healthcare Expenditure
    4.2.3 Emergence of New Technologies such as Biomarkers and Point of Care Testing
    4.3 Market Restraints
    4.3.1 Limited Use in the Emerging Markets
    4.3.2 Expensive Diagnostic Procedures
    4.4 Porter’s Five Force Analysis
    4.4.1 Threat of New Entrants
    4.4.2 Bargaining Power of Buyers/Consumers
    4.4.3 Bargaining Power of Suppliers
    4.4.4 Threat of Substitute Products
    4.4.5 Intensity of Competitive Rivalry

    5.1 Diagnotic Type
    5.1.1 Diagnostic Imaging Tests
    5.1.2 Biopsy and Cytology Tests
    5.1.3 Tumor Biomarkers
    5.1.4 Others
    5.2 Application
    5.2.1 Breast Cancer
    5.2.2 Lung Cancer
    5.2.3 Cervical Cancer
    5.2.4 Kidney Cancer
    5.2.5 Liver Cancer
    5.2.6 Pancreatic Cancer
    5.2.7 Ovarian Cancer
    5.2.8 Others
    5.3 Geography
    5.3.1 North America US Canada Mexico
    5.3.2 Europe Germany UK France Italy Spain Rest of Europe
    5.3.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
    5.3.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
    5.3.5 South America Brazil Argentina Rest of South America

    6.1 Company Profiles
    6.1.1 Abbott
    6.1.2 Qiagen
    6.1.3 F. Hoffmann-La Roche Ltd
    6.1.4 Siemens Healthcare GmbH
    6.1.5 Thermo Fisher Scientific Inc.
    6.1.6 GE Healthcare
    6.1.7 Hologic Inc.
    6.1.8 Illumina Inc
    6.1.9 Philips Healthcare
    6.1.10 Agilent Technologies Inc



    Contact Us:

    Name: Ajay More

    Phone: US +14242530807/ UK +44 20 3239 8187

    Email: [email protected]

    Our Other Reports:

    Ceramic Fiber Market 2019 Industry Recent Developments, Size, Trends, Global Growth, Recent Developments and Latest Technology, Forecast Research Report 2024

    Wastewater Treatment Services Market 2019 Research by Industry Top Manufacture, Business Opportunities, Industry Share Report, Industry Growth, Size, Regional Analysis and Global Forecast to 2026 | Industry Research Biz

    Global Intraoperative Imaging Market 2019-2024 | Industry Share, Size, Growth Statistics, Business Expansion Plans Forecast to 2024

    Outdoor Rock Speaker Market 2019 | Global Industry Demand, Top Leading Countries by Size, Share, Future Growth Rate, and Investment by Forecast to 2023

  • Elamal News All Rights Reserved.2019.